185 related articles for article (PubMed ID: 34202711)
1. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.
Romeo G; Ciaffaglione V; Amata E; Dichiara M; Calabrese L; Vanella L; Sorrenti V; Grosso S; D'Amico AG; D'Agata V; Intagliata S; Salerno L
Molecules; 2021 Jun; 26(13):. PubMed ID: 34202711
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent
Fallica AN; Sorrenti V; D'Amico AG; Salerno L; Romeo G; Intagliata S; Consoli V; Floresta G; Rescifina A; D'Agata V; Vanella L; Pittalà V
J Med Chem; 2021 Sep; 64(18):13373-13393. PubMed ID: 34472337
[TBL] [Abstract][Full Text] [Related]
3. Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.
Georgiadis MO; Karoutzou O; Foscolos AS; Papanastasiou I
Molecules; 2017 Aug; 22(9):. PubMed ID: 28841173
[TBL] [Abstract][Full Text] [Related]
4. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of mixed σ
Fallica AN; Ciaffaglione V; Modica MN; Pittalà V; Salerno L; Amata E; Marrazzo A; Romeo G; Intagliata S
Bioorg Med Chem; 2022 Nov; 73():117032. PubMed ID: 36202063
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
[TBL] [Abstract][Full Text] [Related]
7. The expression, function and targeting of haem oxygenase-1 in cancer.
Hjortsø MD; Andersen MH
Curr Cancer Drug Targets; 2014; 14(4):337-47. PubMed ID: 24655000
[TBL] [Abstract][Full Text] [Related]
8. Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death.
Raffaele M; Pittalà V; Zingales V; Barbagallo I; Salerno L; Li Volti G; Romeo G; Carota G; Sorrenti V; Vanella L
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137785
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.
Fallica AN; Pittalà V; Modica MN; Salerno L; Romeo G; Marrazzo A; Helal MA; Intagliata S
J Med Chem; 2021 Jun; 64(12):7926-7962. PubMed ID: 34076441
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor.
Marinissen MJ; Tanos T; Bolós M; de Sagarra MR; Coso OA; Cuadrado A
J Biol Chem; 2006 Apr; 281(16):11332-46. PubMed ID: 16476737
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
[TBL] [Abstract][Full Text] [Related]
12. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.
Salerno L; Romeo G; Modica MN; Amata E; Sorrenti V; Barbagallo I; Pittalà V
Eur J Med Chem; 2017 Dec; 142():163-178. PubMed ID: 28756878
[TBL] [Abstract][Full Text] [Related]
13. Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary
Salerno L; Vanella L; Sorrenti V; Consoli V; Ciaffaglione V; Fallica AN; Canale V; Zajdel P; Pignatello R; Intagliata S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1378-1386. PubMed ID: 34167427
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-1 Inhibitors Induce Cell Cycle Arrest and Suppress Tumor Growth in Thyroid Cancer Cells.
Yang PS; Hsu YC; Lee JJ; Chen MJ; Huang SY; Cheng SP
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149527
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
Curr Med Chem; 2018; 25(42):5803-5821. PubMed ID: 30674243
[TBL] [Abstract][Full Text] [Related]
18. New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.
Ciaffaglione V; Intagliata S; Pittalà V; Marrazzo A; Sorrenti V; Vanella L; Rescifina A; Floresta G; Sultan A; Greish K; Salerno L
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168943
[TBL] [Abstract][Full Text] [Related]
19. Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes.
Podkalicka P; Mucha O; Kruczek S; Biela A; Andrysiak K; Stępniewski J; Mikulski M; Gałęzowski M; Sitarz K; Brzózka K; Józkowicz A; Dulak J; Łoboda A
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963199
[TBL] [Abstract][Full Text] [Related]
20. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
